GIMOTI
METOCLOPRAMIDE HYDROCHLORIDE
- Strength
- 15 mg/.07mL
- Form
- Spray
- Class
- Dopamine-2 Receptor Antagonist
Evoke Pharma, Inc.
Listed by HF Acquisition Co LLC, DBA HealthFirst
| Dosage form | Injection, Solution |
|---|---|
| Route | Intramuscular, Intravenous |
| Drug class | Dopamine-2 Receptor Antagonist |
| Approval route | ANDA — approved generic |
| NDC code | 51662-1367 |
| FDA application | ANDA091392 |
| RxNorm concept | 727619 |
| Package sizes listed | 1 |
| Marketed since | October 2019 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
METOCLOPRAMIDE HYDROCHLORIDE
Evoke Pharma, Inc.
Medical Purchasing Solutions, LLC.
NCS HealthCare of KY, LLC dba Vangard Labs
Teva Parenteral Medicines, Inc.
metoclopramide hydrochloride
Avenacy, LLC
Cardinal Health 107, LLC
Cardinal Health 107, LLC
NuCare Pharmaceuticals,Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.